Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017
Alemtuzumab for Multiples Sclerosis: Who and When to treat?
Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Human Herpesvirus-6:Clinical Implications of a Recently Discovered, Ubiquitous Agent
J Pediatr 121:173-181, Leach,C.T.,et al, 1992
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Alzheimer Neurofibrillary Tangles in Diseases Other Than Senile & Presenile Dementia
Ann Neurol 5:288-294, Wisniewski,K.,et al, 1979